Back to results
US 8,569,490 B2Granted
Intermediate and process for preparing entecavir using same
AssigneeHanmi Science Co., Ltd.
InventorsJaeheon Lee, Gha-Seung Park, Jin Hee Kim, Ji Eun Lee, Chul Hyun Park, Tae Jin Choi, Eun-Ju Park, Cheol Kyung Kim, Eun Jung Lim, Young-Kil Chang, Gwan Sun Lee
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel, high-yield and low-cost method for preparing entecavir, [1-S-(1α,3α,4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one, an antiviral agent, and novel intermediates used therein.
Claims10
A method of preparing entecavir of formula (1), comprising the steps of
- (a) conducting olefination of an α-hydroxy ketone compound of formula (2) to obtain an exomethylene compound of formula (3);
- (b) carrying out a Mitsunobu reaction of the exomethylene compound of formula (3) with a purine derivative to obtain a nucleoside compound of formula (4);
- (c) removing the protecting groups of the nucleoside compound of formula (4) to obtain a compound of formula (5);
- and
- (d) hydrolyzing the compound of formula (5):
- wherein
- R1 and R2 are each independently H or a hydroxy-protecting group, or R1 and R2 are fused together to form a cyclic hydroxy-protecting group;
- R3 is selected from the group consisting of H, alkylsilyl, and allylsilyl;
- and
- X is selected from the group consisting of chloro, iodo, and benzyloxy.
7 more elements
Dependencies are inferred from the claim text.